Sign in
Taking people in United StatesNo phase

Online psychological support for mothers expecting a baby with congenital heart disease

Tests HeartGPS, an online psychological program, in mothers of babies with congenital heart disease.

Key facts

Who runs it
Carelon Research
Where
Ann Arbor, Atlanta, Aurora, Boston, Charleston, Chicago, Cincinnati, Kansas City, Lexington, Los Angeles, Memphis, New York, Phoenix, Pittsburgh, Salt Lake City, and St Louis, United StatesSee the 17 sites
Trial code
Registry title
Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
Status
Recruiting
People taking part
210 people, planned
Started
22 Jul 2026
Expected to end
Aug 2030
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • HeartGPS
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant people whose unborn baby has congenital heart disease (CHD), or birth mothers of a newborn with CHD. Both mothers and babies take part.

Age
Mothers must be 18 years or older.
Sex
Mothers who are pregnant or gave birth to the baby. Babies of any sex.
Disease stage
The baby's CHD was found between 16.0 and 30.0 weeks of pregnancy. The baby is expected to need heart surgery or a catheter procedure in the first 30 days of life. Only one baby in the pregnancy.

Main reasons for not taking part

  • CHD found only after birth.
  • Baby has another condition with a major effect on development, such as Trisomy 21 or DiGeorge syndrome.
  • Mother has a severe untreated mental health condition or substance use disorder.
  • Mother is under 18 years, or is carrying a pregnancy as a surrogate.
  • Mother cannot give consent, or completes less than 70% of the first survey.

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Pregnant individual carrying a fetus diagnosed with CHD or biological mother of an infant diagnosed with CHD in the neonatal period
  • Fetus or newborn with CHD anticipated to require cardiac surgery or transcatheter intervention in the first 30 days of life
  • CHD diagnosis received between 16.0 and 30.0 weeks gestation
  • Singleton pregnancy
  • Pregnant mother is planning to continue the pregnancy and pursue surgical or transcatheter intervention for the infant
  • Pregnant mother is able to participate and complete study assessments in English or Spanish

Who cannot take part

  • Mother, fetal, or infant medical condition determined by a treating clinician to be contraindicative to study participation
  • Mother with a severe, untreated psychiatric condition, substance use disorder, or other circumstances that, in the opinion of the investigator, would interfere with engagement with study tasks or safe participation in the trial
  • Fetus with a comorbid condition with a predictable and major impact on neurodevelopment (e.g., Trisomy 21, DiGeorge syndrome)
  • Pregnant individual is aged <18 years
  • Mother with a moderate to severe intellectual disability or is otherwise unable to provide informed consent
  • Postnatal diagnosis of CHD
  • Pregnant individual is carrying a surrogate pregnancy
  • Consented mother completes <70% of survey questions at first (baseline) assessment

Other criteria

  • Both mothers and infants are study participants

Where in United States

  • University of Michigan Health System, Ann ArborAnn Arbor, United StatesContact: Principal InvestigatorTaking people
  • Children's Healthcare of AtlantaAtlanta, United StatesContact: Principal InvestigatorTaking people
  • Children's Hospital ColoradoAurora, United StatesContact: Principal InvestigatorNot yet recruiting
  • Boston Children's HospitalBoston, United StatesContact: Principal InvestigatorNot yet recruiting
  • Medical University of South CarolinaCharleston, United StatesContact: Principal InvestigatorTaking people
  • Lurie Children's HospitalChicago, United StatesContact: Principal InvestigatorNot yet recruiting
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Principal InvestigatorTaking people
  • Children's Mercy HospitalKansas City, United StatesContact: Principal InvestigatorNot yet recruiting
  • Golisano Children's at UKLexington, United StatesContact: Principal InvestigatorNot yet recruiting
  • Children's Hospital of Los AngelesLos Angeles, United StatesContact: Principal InvestigatorNot yet recruiting
  • Le Bonheur Children's HospitalMemphis, United StatesContact: Principal InvestigatorTaking people
  • Children's Hospital of New YorkNew York, United StatesContact: Principal InvestigatorNot yet recruiting
  • Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Principal InvestigatorNot yet recruiting
  • Phoenix Children s HospitalPhoenix, United StatesContact: Principal InvestigatorNot yet recruiting
  • University of Pittsburgh School of MedicinePittsburgh, United StatesContact: Principal InvestigatorNot yet recruiting
  • Primary Children's Medical CenterSalt Lake City, United StatesContact: Principal InvestigatorNot yet recruiting
  • Washington University School of MedicineSt Louis, United StatesContact: Principal InvestigatorNot yet recruiting

About the trial

What the trial wants to find out

This is a two-arm, prospective, longitudinal, randomized controlled trial (RCT) that will compare usual care to usual care plus a prenatally initiated, virtually administered psychological intervention, called HeartGPS.

The 2 groups in the trial

  • Usual Fetal Cardiac CareNo study treatment, for comparison

    This is standard of care.

  • HeartGPSTreatment being tested

    Usual Fetal Cardiac Care + HeartGPS intervention. GPS stands for Guiding parents through emotions, Providing information and support, and Strengthening connections. The HeartGPS intervention includes three key components tailored to the CHD population: 1. Eight virtually administered counseling sessions, 2. Tailored educational resource, 3. Mental health care plan.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
BOND HeartGPS: A Longitudinal Randomized Controlled Trial Examining the Maternal and Infant Effects of a Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
Plain-language title
Online psychological support for mothers expecting a baby with congenital heart diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
10 September 2026